Bajaj Healthcare Limited has informed the Exchange regarding Appointment of Mr Gopalakrishnan Kesavan as Non- Executive Independent Director of the company w.e.f. August 18, 2025.
BAJAJHCARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bajaj Healthcare has appointed Mr. Gopalakrishnan Kesavan as an Additional Director in the Non-Executive Independent Director category, effective August 18, 2025. He will serve a first term of five years, running until August 17, 2030, subject to shareholder approval. The appointment was recommended by the Nomination & Remuneration Committee and approved via a board resolution passed by circulation. Mr. Kesavan is a veteran pharmaceutical marketing professional with decades of experience at companies like Johnson & Johnson, Glenmark Pharmaceuticals, Concept Pharmaceuticals, and DWD Pharmaceuticals, and he previously founded Nithyasha Healthcare. He has confirmed meeting the independence criteria under the Companies Act and SEBI Listing Regulations, and is not debarred from holding a director's office.
This is a routine governance update with no direct impact on shareholders or stock price. Adding an experienced pharma marketing veteran to the board could strengthen strategic oversight of the company's pharmaceutical business.